The role of Covid-19 outbreak on well-being of healthcare employees of Turkey by considering gender differences.

In this paper, we explore the role of the Covid-19 outbreak on the well-being of healthcare employees (HE) in Turkey by adopting a survey method with 680 (188 men and 492 women) participants. Our results indicate that both the outbreak negatively affects the well-being of HE, and women face more levels of fear, negative feelings and violence than men. Within the context of this research, we contribute to the literature by considering the changing living conditions in the outbreak and adopting a comprehensive approach to reveal sub-level of well-being as subjective and psychological well-being rather than focusing on only mental health like previous studies.

Predictive Value of Additional Clinical and Radiological Parameters for Discrimination of Malignancy in Bosniak 3 Cysts.

INTRODUCTION: Almost half of the cystic renal lesions are still overdiagnosed and overtreated. New clinical and radiological parameters are needed to distinguish the malignant Bosniak 3 lesions from the benign ones. We aimed to evaluate the clinical and radiological parameters that may be related to malignancy risk for Bosniak category 3 renal cysts. MATERIALS AND METHODS: Patients who underwent surgical resection of a histopathologically confirmed Bosniak 3 renal cyst between March 2007 and September 2019 were evaluated. Two experienced uro-radiologists have reevaluated the last preoperative computed tomography and/or MRI images of the patients and reclassified the lesions according to the Bosniak classification. They also reported cystic features such as nodularity, septation, focal thickening, enhancement, and calcification. Clinical, pathological, and oncological outcomes were recorded. Then patients were divided into 2 groups as Group 1 (benign pathology) and Group 2 (malignant pathology) according to final histopathological report. RESULTS: A total of 79 patients were included in this study. Mean follow-up time was 47 ± 34 months. There were 30 patients in Group 1 and 49 patients in Group 2. Hypertension (p = 0.001) and smoking history (p = 0.008) were more common in malignant group. Among the radiological findings, lower tumor diameter (p = 0.024), presence of cyst wall enhancement (p = 0.025), presence of nodularity (p = 0.002), and presence of focal thickening (p = 0.031) were found to be statistically significant for malignancy. Most of the tumors were at pathological T1 stage and Fuhrmann Grade 1-2. Only nodularity was found to be independent predictive factor for malignancy in multivariate analysis. CONCLUSION: Clinical factors including hypertension and smoking, radiological factors including lower lesion size, cyst wall enhancement, nodularity, and focal thickening were predictors for malignancy of Bosniak 3 cysts.

Comparison of S.T.O.N.E and CROES nephrolithometry scoring systems for predicting stone-free status and complication rates after percutaneous nephrolithotomy: a single center study with 262 cases.

The aim of this study was to compare the accuracy of the CROES nephrolithometric nomogram and S.T.O.N.E. scoring system in predicting PCNL outcomes in terms of stone-free rate, estimated blood loss (EBL), operative time (OR), length of hospital stay (LOS), and complications. Patients who underwent PCNL for renal stones between May 2012 and January 2015 were analyzed retrospectively. The patients' demographic characteristics and operational features were recorded prospectively in all patients postoperatively. S.T.O.N.E. and CROES nephrolithometry scores' correlation with stone-free status, operation and fluoroscopy time, length of hospital stay (LOS) and blood loss (BL) was evaluated. Patients were categorized according to S.T.O.N.E. nephrolithometry and CROES nephrolithometry scores. Postoperative complications were graded according to modified Clavien classification (Dindo et al. in Ann Surg 240:205-213, 2004) and the correlation of both scoring systems with postoperative complications was also evaluated. We identified 437 patients who underwent PCNL between May 2012 and January 2015. A total of 262 patients who are available data for the CROES and S.T.O.N.E. scoring systems were included in the recent study. The mean S.T.O.N.E score was 7.65 ± 1.56 and the mean CROES score was 191.13 ± 64.39. The overall stone-free rate was 71.4%. Of the 262 patients, 89 experienced postoperative complications. Stone-free patients had significantly lower BMI (<0.001) and stone burden (p < 0.001). Regression analysis showed that both scoring systems were significantly associated with stone-free rates and operation time. We demonstrated that S.T.O.N.E. and CROES scoring systems were useful for predicting post-PCNL stone-free status. But both scoring systems were not useful for predicting post-PCNL complications.

A Novel Pain Alternative for Patients with Anorectal Pathologies: The Comparison of Transperineal Prostatic Blockage Technique with Periprostatic Nerve Blockage and Rectal Gel Technique in Initial Transrectal Ultrasound-Guided Prostate Biopsy - A Prospective, Randomized Trial.

INTRODUCTION: The study aimed to compare the efficiency of periprostatic nerve blockage (PPNB) and intrarectal lidocaine gel (PPNB + gel) with a transperineal prostatic block (TPPB) technique during transrectal ultrasound-guided prostate biopsy (TRUS-PBx) in patients with anorectal pathologies. MATERIALS AND METHODS: A total of 376 patients who underwent TRUS-PBx were randomized into 2 groups. Group-I (n = 198) received TPPB with 10 ml 2% prilocaine, and group-II (n = 178) received intrarectal administration of 10 ml 2% lidocaine gel followed by PPNB with 10 ml 2% prilocaine. A 10-point linear visual analogue scale (VAS) was used to assess the pain arising from probe insertion (VAS-1) and prostate sampling (VAS-2). RESULTS: VAS-1 scores were significantly lower in group-I than group-II (1.7 ± 1.9 vs. 3.9 ± 1.5; p < 0.001). Combining local anesthesia produced superior pain control to TPPB during sampling (2.0 ± 1.2 vs. 2.5 ± 2.4; p = 0.015). Following subgroup analyses with reference to concomitant anorectal pathologies, VAS-1 scores were significantly lower in group-I than group-II (2.0 ± 1.8 vs. 5.5 ± 1.7; p < 0.001). VAS-2 scores were lower in group-II than group-I; however, the difference was not considered significant (2.4 ± 1.3 vs. 3.1 ± 2.8; p = 0.303). CONCLUSIONS: In all patients referred for TRUS-PBx, TPPB is a good alternative to PPNB + gel. TPPB can be particularly useful for patients with anorectal pathologies due to its improved pain reduction during probe insertion.

Comparing the short-term outcomes and complications of monopolar and bipolar transurethral resection of non-muscle invasive bladder cancers: a prospective, randomized, controlled study.

OBJECTIVES: To compare perioperative outcomes and complications of plasmakinetic bipolar and monopolar transurethral resection of bladder tumors (TURBT) in patients with non-muscle invasive bladder cancer (NMIBC). METHODS: Between March and December 2015, a total of 130 consecutive patients underwent TURBT for NMIBC. Patients were equally randomized into monopolar TURBT (M-TURBT) and bipolar TURBT (B-TURBT) groups. Primary outcome of this study was safety of the procedures including obturator jerk, bladder perforation, clot retention, febrile urinary tract infection and TUR syndrome. The secondary outcome was efficacy of both TURBT procedures, including complete tumor resection, sampling of the deep muscle tissue and sampling of the qualified tissues that without any thermal damage. RESULTS: Complete tumor resection rate was higher in B-TURBT than M-TURBT (89.2% vs 78.5%, respectively), but the difference was not significant (p=0.152). No significant differences were found between the muscle tissue sampling rates (64.6% vs 72.3%, p=0.345) and the numbers of patients with thermal tissue damage (7 patients vs 3 patients, p=0.194). Obturator jerk was detected in 21.5% of the patients in M-TURBT group and 4.6% of the patients in B-TURBT group, and this difference was statistically significant (p=0.013). Bladder perforation was significantly higher in M-TURBT group than B-TURBT (21.5 % vs 6.1%, p=0.039). CONCLUSIONS: Bipolar TURBT had significantly lower obturator jerk and bladder perforation than monopolar. B- TURBT is a reasonable treatment modality in patients with NMIBC.

Immediate vs. delayed loading in the posterior mandible: a split-mouth study with up to 15 years of follow-up.

PURPOSE: The aim of this study was to evaluate the long-term clinical and radiographic outcomes of implants that were immediately loaded in a prospective, randomized, split-mouth clinical trial in the posterior mandible. MATERIALS AND METHODS: Patients with alveolar ridges that were bilaterally edentulous distal to the canines were enrolled to participate. On one randomly selected side of each patient's jaw, three implants (control group) with platform switching and a progressive thread design were placed, allowed to heal for 3 months, uncovered, and loaded occlusally using resin-splinted crowns, which then were replaced 6 weeks later by final prostheses. Three additional implants (test group) of the same size and design were placed on the contralateral side of each patient in symmetrical locations. The test implants were connected to their final abutments immediately after placement and immediately loaded. Periodontal indices and bone loss were evaluated at regular intervals. RESULTS: After a mean loading period of 12.14 (±0.89) years for the test group and 12.40 (±0.89) years for controls, differences between the immediately and delayed loaded implants were not statistically significant (P > 0.05). The crestal bone loss was (mesial) 0.70 (±1.09) mm (test group) and 1.17 (±1.27) mm (control group) and the distal bone loss was 0.43 (±1.02) mm (test group) and 1.06 (±1.33) mm (control group) (P > 0.05). The maximum crestal bone loss was 3.12 mm for the test group and 3.78 mm for the controls after 10.125/10.397 years, respectively. CONCLUSION: Immediate loading does not negatively influence the long-term prognosis of dental implants in the posterior mandible, improves the implant stability, and is associated with minimal crestal bone loss when platform switching and a one-abutment concept with a Morse-tapered connection are used.

Long-term results after subcrestal or crestal placement of delayed loaded implants.

PURPOSE: Prevention of peri-implant bone loss is essential for achieving long-term implant success, but few studies have evaluated the impact of placement depth on long-term bone loss. The aim of this retrospective study was to evaluate outcomes for platform-shifted implants placed at different depths relative to the bone crest. MATERIALS AND METHODS: The mesial and distal shoulders of 228 delayed-loaded Ankylos® (Dentsply Implants Manufacturing GmbH, Mannheim, Germany) implants placed in 85 patients were divided retrospectively into two groups based on the implant shoulder position on the day of placement surgery as follows: subcrestal group A (n = 197; 0.5 mm or more below the crestal bone level) or crestal group B (n = 65; within 0.5 mm or less of the crestal bone level). The remaining sites (n = 194; more than 0.5 mm above the crestal bone level) were supracrestal and were excluded from this analysis. Mesial and distal bone loss was evaluated under 5× magnification and analyzed, along with Periotest values. RESULTS: Mean Periotest values were -1.77 (±3.57) for Group A and -1.77 (±3.26) for Group B. For Group A, mean mesial (m) bone loss was 1.84 (±1.49 mm) and mean distal (d) bone loss was 1.73 (±1.31 mm). For Group B, the bone loss values were m: 1.41 (±1.65 mm) and d: 1.34 (±1.60 mm). No statistically significant differences were found for the Periotest values (p = .521) or bone level values for the two groups (m: p = .130; d: p = .153). CONCLUSION: Within the limitations of this study, subcrestal or crestal implant placement in combination with delayed loading was associated with similar initial implant stability and subsequent crestal bone loss.

Long-term results after immediate loading of platform-switched implants in smokers versus nonsmokers with full-arch restorations.

PURPOSE: Few studies have compared the effects of immediate loading on implant prognoses in smokers and nonsmokers. The aim of this prospective study was to evaluate the long-term success of immediately loaded platform-switched implants placed in smokers and nonsmokers with edentulous jaws. MATERIALS AND METHODS: Platform-switched implants were placed using the same treatment protocol in the healed edentulous jaws of two groups of patients: group A patients had smoked at least 20 cigarettes a day for more than 10 years, and group B consisted of nonsmokers. All implants were loaded immediately with provisional fixed prostheses, and definitive cement-retained restorations were delivered 4 to 6 weeks later without removing the abutments. In a standardized follow-up protocol, the implants were evaluated clinically and radiographically at the start of loading, 4 to 6 weeks later, and annually thereafter. RESULTS: Sixty-six implants (36 in the maxilla and 30 in the mandible) were placed in eight smokers. Twelve nonsmokers received 97 implants (55 in the maxilla and 42 in the mandible). During an average loading period of 62.53 (± 44.13) months for the smokers and 98.20 (± 19.53) months for the nonsmokers, three implants failed. Two failed in group A (one because of overloading and one because of peri-implanitis) and one failed in group B (overloading), resulting in implant survival rates of 97% and 99%, respectively. No significant differences were found between groups regarding plaque, bleeding, probing pocket depths, or crestal bone loss, either mesially or distally, resulting in success rates of 92.42% for group A and 98.00% for group B. CONCLUSIONS: Long-term clinical outcomes for immediately loaded platform-shifted implants placed in heavy smokers appear to be comparable to those for nonsmokers if the abutments are placed on the day of surgery and never removed.